---
title: "Astal Laboratories Ltd (512600) — Share Price, Financials & Analysis"
symbol: "512600"
company: "Astal Laboratories Ltd"
canonical: "https://tapetide.com/stocks/512600"
isin: "INE307N01014"
nse_symbol: "MACROINTERNATIONALEXPORTLTD"
bse_code: "512600"
sector: "Commercial Services"
industry: "Trading & Distributors"
market_cap_cr: 328.93
generated_at: "2026-09-13T18:47:05.487Z"
---

# Astal Laboratories Ltd (512600)

Canonical page: https://tapetide.com/stocks/512600

## Company

- **NSE Symbol:** MACROINTERNATIONALEXPORTLTD
- **BSE Code:** 512600
- **ISIN:** INE307N01014
- **Sector:** Commercial Services
- **Industry:** Trading & Distributors
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** astallabs.com

## About

Astal Laboratories Ltd is engaged in Manufacturing and Trading of all kinds of active Pharmaceutical Ingredients (Bulk Drugs).[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:48:39.750319Z.

- **Market Cap:** ₹328.93 Cr
- **Classification:** Microcap
- **P/E (reported):** 22.6
- **EPS (reported):** ₹2.81
- **Book Value:** ₹77.65
- **Price to Book:** 0.98
- **Dividend Yield:** 0%
- **ROE:** 24.8%
- **ROCE:** 34.67%
- **Debt to Equity:** 0.15
- **Revenue (yearly):** ₹156 Cr
- **Net Income:** ₹8.28 Cr
- **EBITDA:** ₹12.78 Cr
- **52-Week High:** ₹103.2
- **52-Week Low:** ₹60.45
- **RSI (14):** 41.98

## Tapetide Score

- **Score:** 60 / 100
- **Score date:** 2026-09-04
- **Archetype:** Cheap but Weak
- **What it means:** A low multiple sitting on weak financials. Worth establishing what the market is discounting before treating the low valuation as an opportunity — weak fundamentals often justify it.
- **Pillar profile:** Quality: Weak · Valuation: Cheap · Momentum: Flat
- **Percentile:** 87.9 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 58.47 | 9% |
| growth | 98.9 | 9% |
| momentum | 58.9 | 12% |
| ownership | 50 | 24% |
| quality | 43.65 | 22% |
| valuation | 67.16 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.96 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 4.53%
- Company has high debtors of 229 days.
- Promoter holding has decreased over last 3 years: -56.6%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -124.37% | -769.44% | — |
| ebitda margin growth | 20.39% | -59.2% | 71.85% | -787.39% |
| net income growth | 22.08% | -6.97% | 935% | — |
| revenue growth | -24.66% | 142.24% | 87.41% | 278.81% |
| roce | — | 645.59% | — | 7.95% |
| roe | — | 638.1% | 9.49% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- |
| Sales | 23.47 | 52.24 | 134.05 | 100.94 |
| Expenses | 19.29 | 48.69 | 123.86 | 88.69 |
| Operating Profit | 4.18 | 3.55 | 10.19 | 12.25 |
| OPM % | 17.81 | 6.8 | 7.6 | 12.14 |
| Other Income | 0.04 | 0.04 | 0.1 | 0.14 |
| Interest | 0.27 | 0.33 | 1.09 | 1.18 |
| Depreciation | 0.1 | 0.12 | 0.86 | 0.86 |
| Profit before tax | 3.85 | 3.14 | 8.34 | 10.35 |
| Tax % | 28.57 | 24.52 | 7.91 | 8.99 |
| Net Profit | 2.74 | 2.36 | 7.68 | 9.42 |
| EPS in Rs | 2.79 | 2.19 | 1.82 | 2.15 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Mar 2026 |
| --- | --- | --- |
| Sales | 64 | 249 |
| Expenses | 51 | 228 |
| Operating Profit | 13 | 21 |
| OPM % | 20 | 8 |
| Other Income | 0 | 0 |
| Interest | 1 | 2 |
| Depreciation | 0 | 1 |
| Profit before tax | 12 | 18 |
| Tax % | 25 | 17 |
| Net Profit | 9 | 15 |
| EPS in Rs | 9.08 | 3.48 |
| Dividend Payout % | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Mar 2026 |
| --- | --- | --- |
| Equity Capital | 10 | 42 |
| Reserves | 26 | 292 |
| Borrowings | 13 | 50 |
| Other Liabilities | 14 | 135 |
| Total Liabilities | 63 | 518 |
| Fixed Assets | 11 | 268 |
| CWIP | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 52 | 251 |
| Total Assets | 63 | 518 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Mar 2026 |
| --- | --- | --- |
| Cash from Operating Activity | -13 | -18 |
| Cash from Investing Activity | -8 | -2 |
| Cash from Financing Activity | 3 | 3 |
| Net Cash Flow | -17 | -17 |
| Free Cash Flow | -18 | -19 |
| CFO/OP | -96 | -80 |

### Ratios

| Item | Mar 2025 | Mar 2026 |
| --- | --- | --- |
| Debtor Days | 157 | 229 |
| Inventory Days | 112 | 113 |
| Days Payable | 82 | 206 |
| Cash Conversion Cycle | 187 | 135 |
| Working Capital Days | 97 | 114 |
| ROCE % | — | 9 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 55.72% | 39.79% | 19.93% | 19.93% | 19.93% | 19.93% | 19.93% | 19.93% | 18.19% | 18.19% | 4.7% | 4.53% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 41.87% | 55.29% | 73.53% | 73.49% | 73.42% | 73.04% | 73.8% | 73.42% | 73.5% | 73.06% | 80.1% | 80.88% |
| Others | 2.4% | 4.92% | 6.54% | 6.58% | 6.65% | 7.03% | 6.26% | 6.65% | 8.31% | 8.75% | 15.2% | 14.59% |
| No. of Shareholders | 1169 | 1185 | 1241 | 1242 | 1629 | 1925 | 2302 | 2721 | 2899 | 2926 | 3065 | 3274 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 0 / 7 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 77.48 | Sell |
| EMA (10) | 77.53 | Sell |
| SMA (20) | 79.36 | Sell |
| EMA (20) | 78.93 | Sell |
| SMA (50) | 81.17 | Sell |
| EMA (50) | 79.96 | Sell |
| SMA (100) | 78.29 | Sell |
| EMA (100) | 79.47 | Sell |
| SMA (200) | 78.76 | Sell |
| EMA (200) | 79.78 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 43 | Neutral |
| MACD (12,26,9) | -1.56 | Sell |
| Stochastic (14,3,3) | 58.01 | Neutral |
| ADX (14) | 24.14 | Neutral |
| Williams %R (14) | -41.99 | Neutral |
| ATR (14) | 4.25 | High Volatility |
| ROC (12) | -6.77 | Sell |
| Stoch RSI (14) | 49.44 | Neutral |
| UO (7,14,28) | 61.65 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - Submitted RTA certificate under Regulation 74(5) for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - Submitted RTA certificate under Regulation 74(5) for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/acd4ff65-0d0e-45f2-a67a-12ccf412254b.pdf) |
| 7h - Astal Laboratories confirms it is not a Large Corporate; outstanding borrowing was Rs 11.80 crore. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 7h - Astal Laboratories confirms it is not a Large Corporate; outstanding borrowing was Rs 11.80 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1373af8d-62de-486f-b8e9-7a49a2b1c167.pdf) |
| 5h - Company says recent share price movement is market-driven and no undisclosed material event exists. | [Price Movement Clarification 5h - Company says recent share price movement is market-driven and no undisclosed material event exists.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/220e4e10-ed49-497b-b008-4ab1ea58b0fe.pdf) |
| 30 Apr - Astal Laboratories intimates its official website address, https://astallabs.com/, under SEBI LODR Regulation 46. | [Intimation Under Regulation 30 (LODR), 2015- Website 30 Apr - Astal Laboratories intimates its official website address, https://astallabs.com/, under SEBI LODR Regulation 46.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0f3eefe1-7a9e-4159-8fab-a2fa534df43e.pdf) |
| 30 Apr - Astal Laboratories intimates its official website address, https://astallabs.com/, under SEBI LODR Regulation 46. | [Intimation Under Regulation 30 (LODR), 2015- Website 30 Apr - Astal Laboratories intimates its official website address, https://astallabs.com/, under SEBI LODR Regulation 46.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0f3eefe1-7a9e-4159-8fab-a2fa534df43e.pdf) |
| 3 Feb - Board meeting on 12 Feb 2026 at 4:00PM to approve unaudited standalone results for quarter ended 31 Dec 2025. | [Board Meeting Intimation for Prior Intimation Of Board Meeting 3 Feb - Board meeting on 12 Feb 2026 at 4:00PM to approve unaudited standalone results for quarter ended 31 Dec 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/55705c73-bb73-4cb7-843b-197e81f3cc74.pdf) |
| 27 Apr - Astal Laboratories confirms it is not a Large Corporate; outstanding borrowing was Rs 11.80 crore. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 27 Apr - Astal Laboratories confirms it is not a Large Corporate; outstanding borrowing was Rs 11.80 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1373af8d-62de-486f-b8e9-7a49a2b1c167.pdf) |
| 19 Mar - Received Form C (Reg.7(2)) on 19-Mar-2026: promoter ACESO Research Labs LLP purchased shares. | [Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015 19 Mar - Received Form C (Reg.7(2)) on 19-Mar-2026: promoter ACESO Research Labs LLP purchased shares.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3143667c-b275-4184-b016-f9cf7c413596.pdf) |
| 14 Feb - Statement of deviation: Rs281.98L raised 12-Aug-2025; Rs218.10L utilised by 31-Dec-2025; no deviation. | [Compliances- Statement Of Deviation & Variation 14 Feb - Statement of deviation: Rs281.98L raised 12-Aug-2025; Rs218.10L utilised by 31-Dec-2025; no deviation.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ba8da54d-1806-47df-875e-1dd5ea343105.pdf) |
| 14 Feb - Board approved unaudited Q3 results for quarter ended 31-Dec-2025; limited review report attached. | [Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 14Th February, 2026. 14 Feb - Board approved unaudited Q3 results for quarter ended 31-Dec-2025; limited review report attached.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/71304949-7ade-415b-b97d-46b1e8e0af8c.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e95c83f-4fc3-4b2a-8709-430bd58c8718.pdf) |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87cc4641-900a-4f19-bf50-07463c667574.pdf) |
| 2026-09-07 | [Shareholders Meeting - Notice Of 33Rd Annual General Meeting To Be Held On Tuesday 29Th September 2026 Through VC/OAVM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9af894ee-3584-4214-9796-7dca48a2b343.pdf) |
| 2026-09-07 | [Announcement Under Regulation 30 (LODR) - Letter Of Annual Report & AGM Notice Web Link.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=705f30a4-c643-43df-b4a9-00c30899a024.pdf) |
| 2026-09-05 | [Announcement Under Regulation 30 (LODR)- Appointment Of Cost Auditor.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87c0d9c9-42d0-4f16-b627-78dffe937c41.pdf) |
| 2026-09-05 | [Shareholders Meeting - AGM On September 29 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=866beec9-a815-45da-81f7-a1a78677a11b.pdf) |
| 2026-09-04 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 04Th September 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b987d5ec-9885-4f86-9398-68a5fd0cf0e9.pdf) |
| 2026-08-31 | [Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday 04Th September 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a15ad60-1d19-4c72-9818-15c08e0978f6.pdf) |
| 2026-08-16 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a50c2428-bfdd-42a8-93b2-4e76e0ea0911.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 14Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ebe25a1-0a56-4d50-a3c3-275cdc26fe62.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Results- Financial Results For June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00545b33-0e27-40e7-86fe-f699067c9dc8.pdf) |
| 2026-05-30 | [Results- Financial Results For March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3afc74f6-508d-468c-813c-be74fbbf4c7a.pdf) |
| 2026-05-30 | [Results- Financial Results For March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecabda27-6500-4573-a6a1-ed26e9e7cf07.pdf) |
| 2026-02-14 | [Results- Financial Results For December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=548faed2-ce52-474d-bc55-7f3396584e14.pdf) |
| 2025-11-14 | [Results- Financial Results For September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=270d34ee-1d28-4d54-8a8c-03b7831d8b85.pdf) |
| 2025-08-12 | [Results- Financial Results For The Quarter June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6995c7d1-d68a-44e5-af7f-d6eebd1c2fb8.pdf) |
| 2025-05-19 | [Results- Financial Results For March 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=604a0af2-3817-4e0b-8659-4f32abea4fbb.pdf) |
| 2025-01-27 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 27Th January 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56b921b3-7d96-417c-aef9-6430764a6a6a.pdf) |
| 2025-01-27 | [Results- Financial Results For The Quarter Ended December 31 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0a38257-f21b-4aac-bc1f-727f15a8c8d2.pdf) |
| 2024-11-12 | [Results- Financial Results For September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60bb4b2e-9823-4b83-a156-a36add17904d.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4db57508-fd7a-430b-959f-3cbec379f503.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6796438d-fd71-4788-91ec-d4b209588ac5.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4eff18bd-2e5b-431e-9c5e-dcac243e172b.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/85d90952-d9b2-4e82-a64d-edd4b50bbaed.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ec17dcc7-aeb3-4a10-acfe-06e15b0671f2.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a4bf4b72-f920-4bc0-9f6c-ea81238fd101.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/542437/75678542437.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/512600/77070512600.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/542437/71035542437.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/512600/70443512600.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2a5b8e18-86d2-4da0-b3d3-6c475d90fe12.pdf) |
| Aug 2021 | [Concall - Aug 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/28dedb5f-5224-4af5-a081-403129019504.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:47:05.487Z.